About

WWARN has been more than four years in the planning. Beginning with a series of informal meetings co-organized with The Special Programme for Research and Training in Tropical Diseases (WHO/ TDR), a core group of over 50 individuals from 28 malaria endemic countries assembled to lay the foundation for the network in two formal meetings in 2006 and 2008, supported by the Bill & Melinda Gates Foundation (BMGF). A series of papers detailing the vision for the network was published in 2007 (see Documents on the right). Under the current BMGF-funded planning grant, consensus has been reached on the optimal WWARN implementation strategy, potential business models have been evaluated, the constitution and basic governance for WWARN established, and partnership with WHO formulated. We present here plans for implementing WWARN, for managing its growth, and for progressing to its sustainable future.

Our Vision

• We are driven by the needs of malaria-affected countries and guided by scientific evidence.
• We value scientific independence and affirm that the network is the sole executor of its own scientific objectives.
• We value our evolving relationship with the World Health Organization and Ministries of Health in endemic countries.
• We are dedicated to training and building sustainable capacity in malaria endemic countries to strengthen the collection, analysis, interpretation, and dissemination of high quality data on antimalarial drug resistance.
• We intend the network, its tools, and information to be open access.
• We intend the network to facilitate collaboration and provide a forum for global exchange of scientific and public health information.
• We intend to provide data and services to WWARN beneficiaries in a responsive manner, in accord with the urgency of the antimalarial drug resistance problem.